medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2019, Number 2

Next >>

Rev Mex Urol 2019; 79 (2)

Photoselective vaporization of the prostate with 180W GreenLight xps laser and MoXy fiber: Safety and efficacy in patients with obstructive prostatic growth at the Hospital General Dr. Manuel Gea González

Calvo Vázquez I, Rodríguez-Rodríguez B, Hernández-Méndez EA, Haddad-Servin A, Torres-Zazueta J, Cortés-Raygoza P, Ortega-González ME, Sánchez-Aquino UC, Véliz-Cabrera GA, Cantellano-Orozco M, Fernández-Noyola G, Martínez-Arroyo C, Morales-Montor JG, Pacheco-Gahbler C

Language: Spanish
References: 19
Page: 1-9
PDF size: 231.55 Kb.


ABSTRACT

Objective: To present our experience in relation to the safety and efficacy of the 180W Greenlight xps laser for photoselective vaporization of the prostate.
Materials and methods: A retrospective, observational, analytic, and descriptive study was conducted within the time frame of July 2014 to November 2017, evaluating technical aspects and preoperative and postoperative variables at 1, 3, and 6 months.
Results: Fifty-five patients were included in the study. Their mean age was 69 years. A total of 49.1% presented with comorbidities, 14.5% with heart disease, and 20% with an ASA III. The preoperative parameters were: IPSS 14.5 points (5-35), Qmax 7.19 ml/sec (1.5-12), prostate volume 74 cc (29.2-130), PSA 5.7 ng/ml, and Foley catheter placement (54%). Laser use, time with catheter, previous infections, and previous biopsy were described, as were intraoperative complications (10.8%), postoperative complications (27.3%), Clavien-Dindo (C-D) I (80.2%), C-D II (6.6%), and C-D IIIa (13.2%). Postoperative control at 6 months was: Qmax 17.2 ml/sec (10.2-34.4) (p=0.01) and IPSS 4.2 points (0-19) (p=0.02). Surgical reintervention was performed in 3.6% of the patients, hospital stay was 1.5 days, and the mortality rate was 0%.
Conclusions: Photoselective vaporization of the prostate with the GreenLight laser is a safe surgical technique with good results in high-risk surgical patient populations. Complications are similar to those when utilizing the gold standard, but patients taking anticoagulants and antiaggregants can be operated on with the technique and hospital stay is short. Studies with long-term follow-up are needed.


REFERENCES

  1. Kim EH, Larson JA, Andriole GL. Management of Benign Prostatic Hyperplasia. Annu Rev Med. 2016;67:137–51. doi: https://doi.org/10.1146/ annurev-med-063014-123902

  2. Lepor H, Kazzazi A, Djavan B. α-Blockers for benign prostatic hyperplasia: the new era. Curr Opin Urol. 2012;22(1):7–15. doi: https://doi. org/10.1097/MOU.0b013e32834d9bfd

  3. Yeo JK, Choi H, Bae JH, Kim JH, Yang SO, Oh CY, et al. Korean clinical practice guideline for benign prostatic hyperplasia. Investig Clin Urol. 2016;57(1):30–44. [accessed 7 May 2019] Available from: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4778754/

  4. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol. 2008;180(1):241–5; discussion 245. doi: https://doi.org/10.1016/j. juro.2008.03.039

  5. Chander J, Vanitha V, Lal P, Ramteke VK. Transurethral resection of the prostate as catheter-free day-care surgery. BJU Int. 2003;92(4):422–5.

  6. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol. 1999;162(4):1307–10.

  7. Gesenberg A, Sintermann R. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent. J Urol. 1998;160(1):72–6.

  8. Broggi E, May A, Giretti G, Tabchouri N, Lorphelin H, Brichart N, et al. Long-term outcomes of 80-watt KTP and 120-watt HPS GreenLight photoselective vaporization of the prostate. Urol Int. 2014;93(2):229–36. doi: https://doi. org/10.1159/000356991

  9. Sun J, Shi A, Tong Z, Chi C. GreenLight photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml. Lasers Med Sci. 2018;33(8):1693– 8. doi: https://doi.org/10.1007/s10103-018- 2521-x

  10. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. 180-W XPS Green- Light laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol. 2014;65(5):931–42. doi: https://doi. org/10.1016/j.eururo.2013.10.040

  11. Emara AM, Barber NJ. The continuous evolution of the GreenLight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol. 2014;28(1):73–8. doi: https://doi.org/10.1089/end.2013.0356

  12. Wojcik M, Dennison D. Photoselective vaporization of the prostate in ambulatory surgery. AORN J. 2006;83(2):330–4, 337–40, 343–5; quiz 347–50.

  13. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Müller A, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005;47(6):798– 804. doi: https://doi.org/10.1016/j.eururo. 2005.02.003

  14. Muir G, Sancha FG, Bachmann A, Choi B, Collins E, Rosette J de la, et al. Techniques and Training with GreenLight HPS 120-W Láser Therapy of the Prostate: Position Paper. Eur Urol Suppl. 2008;7(4):370–7. [accessed 7 May 2019] Available from: https://www.eusupplements. europeanurology.com/article/S1569- 9056(08)00026-2/abstract

  15. Benejam Gual J, Díez-Caballero Alonso F, García-Miralles Grávalos R, Servera Ruiz de Velasco A. Fotovaporización prostática láser GreenLight HPS en régimen de cirugía mayor ambulatoria. Actas Urol Esp. 2010;34(2):170–5. [accessed 7 May 2019] Available from: http:// www.elsevier.es/es-revista-actas-urologicas-espanolas- 292-articulo-fotovaporizacion-prostatica- láser-GreenLight-hps-S0210480610700358

  16. Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Láser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol. 2016;69(1):94–102. doi: https://doi. org/10.1016/j.eururo.2015.07.054

  17. Benejam-Gual JM, Sanz-Granda Á, Budía A, Extramiana J, Capitán C. Estudio multicéntrico de costes de 2 técnicas quirúrgicas: láser Green- Light XPS 180W vs resección transuretral de la próstata. Actas Urol Esp. 2014;38(6):373–7. [accessed 7 May 2019] Available from: http:// www.elsevier.es/es-revista-actas-urologicasespanolas- 292-articulo-estudio-multicentricocostes- 2-tecnicas-S0210480613003859

  18. Vásquez-Lastra C, Castro-Gaytán A, Cisneros B, Contreras A, Mérigo J, Ochoa G, et al. Vaporización fotoselectiva de la próstata con láser KTP (GreenLight): seguimiento mediante parámetros clínicos y flujométricos. Rev Mex Urol. 2008;68(5):278–82.

  19. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246–9. doi: https://doi.org/ 10.1016/j.juro.2008.03.058




2020     |     www.medigraphic.com